An agonist of GPR55 (EC50 = 2.5 µM in a GTPγS binding assay); selective for GPR55 over CB1 and CB2 (EC50s = >30 µM for both in GTPγS binding assays); a full agonist at GPR18 (EC50 = 0.835 µM for inducing p44/42 MAPK phosphorylation in HEK293 cells expressing GPR18); increases migration of BV-2 microglial cells (EC50 = 0.6 µM); decreases blood pressure in anesthetized rats at 20 µg/g

Abnormal Cannabidiol – 1 mg

Brand:
Cayman
CAS:
22972-55-0
Storage:
-20
UN-No:
De Minimis - 1231 / 3

Abnormal cannabidiol is a synthetic cannabidiol agonist of GPR55 (EC50 = 2.5 µM in a GTPγS binding assay).{17583} It is selective for GPR55 over cannabinoid (CB) receptor 1 (CB1) and CB2 (EC50s = >30 µM for both in GTPγS binding assays). It is also a full agonist at GPR18, with an EC50 value of 0.835 µM for inducing p44/42 MAPK phosphorylation in HEK293 cells expressing GPR18.{40399} Abnormal cannabidiol increases migration of BV-2 microglial cells (EC50 = 0.6 µM).{12500} It induces endothelium-dependent vasodilation via a CB1-CB2-NO-independent mechanism and inhibits vasoconstriction induced by endothelin 1 (ET-1; Item No. 24127) in retinal arterioles, an effect that can be blocked by the calcium-sensitive potassium channel blocker apamin (Item No. 17082).{11092,40401} Abnormal cannabidiol also decreases blood pressure in anesthetized rats when administered intravenously at a dose of 20 µg/g or when administered directly into the rostral ventrolateral medulla at 0.4 and 0.8 µg.{11092,40400}  

 

Available on backorder

Add to quotes
SKU: 10004259 - 1 mg Category:

Description

An agonist of GPR55 (EC50 = 2.5 µM in a GTPγS binding assay); selective for GPR55 over CB1 and CB2 (EC50s = >30 µM for both in GTPγS binding assays); a full agonist at GPR18 (EC50 = 0.835 µM for inducing p44/42 MAPK phosphorylation in HEK293 cells expressing GPR18); increases migration of BV-2 microglial cells (EC50 = 0.6 µM); decreases blood pressure in anesthetized rats at 20 µg/g, i.v. or at 0.4 and 0.8 µg via rostral ventrolateral medulla injection

Formal name: 4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol

Synonyms:  Abn-CBD

Molecular weight: 314.5

CAS: 22972-55-0

Purity: ≥98%

Formulation: A solution in methyl acetate

Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cardiovascular System|Vasculature|Vasodilation||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors

Related products

  • A powerful effector in both the TetR and revTetR transcriptional regulator systems

    Anhydrotetracycline (hydrochloride) – 50 mg

    The tetracycline repressor (TetR) is a transcriptional regulator which normally binds tightly to its palindromic tetO operator DNA, blocking gene expression.{17508} Tet causes the repressor to dissociate from the DNA, allowing transcription to occur. A novel reverse TetR (revTetR) requires tetracycline as a co-repressor to bind tetO and block transcription.{17509,17510} Anhydrotetracycline (hydrochloride) is a powerful effector in both the tetracycline repressor (TetR) and reverse TetR (revTetR) systems, binding the Tet repressor 35-fold more strongly than Tet.{17508,17511} Moreover, anhydrotetracycline poorly binds the 30S ribosomal subunit, compared to Tet,{17512} so it does not act as a general inhibitor of translation and is a poor antibiotic. Perhaps related to this, the concentration of anhydrotetracycline that inhibits eukaryotic cell growth is more than a 1,000-fold above the dose that alters transcription through TetR.{17508}  

     

    Brand:
    Cayman
    SKU:10009542 - 50 mg

    Available on backorder

    Add to quotes
    Add to quotes
    View product page
  • A potent inhibitor of Cdk2/cyclin E with an IC50 value of 0.1 µM; also inhibits Cdk7/cyclin H

    (R)-Roscovitine – 1 mg

    Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising targets for cancer therapy. (R)-Roscovitine is a potent inhibitor of Cdk2/cyclin E with an IC50 value of 0.1 µM.{14988} It also inhibits Cdk7/cyclin H, Cdk5/p35, and cell division cycle (cdc)/cyclin B with IC50 values of 0.49, 0.16, and 0.65 µM, respectively.{14987,14988,14991} (R)-Roscovitine inhibits the growth of rapidly proliferating cells with an average IC50 value of 15.2 µM against a panel of 19 human tumor cell lines.{14988} In murine models of polycystic kidney disease, (R)-roscovitine effectively inhibited disease progression at doses of 50-100 mg/kg.{14564}  

     

    Brand:
    Cayman
    SKU:10009569 - 1 mg

    Available on backorder

    Add to quotes
    Add to quotes
    View product page
  • A powerful effector in both the TetR and revTetR transcriptional regulator systems

    Anhydrotetracycline (hydrochloride) – 500 mg

    The tetracycline repressor (TetR) is a transcriptional regulator which normally binds tightly to its palindromic tetO operator DNA, blocking gene expression.{17508} Tet causes the repressor to dissociate from the DNA, allowing transcription to occur. A novel reverse TetR (revTetR) requires tetracycline as a co-repressor to bind tetO and block transcription.{17509,17510} Anhydrotetracycline (hydrochloride) is a powerful effector in both the tetracycline repressor (TetR) and reverse TetR (revTetR) systems, binding the Tet repressor 35-fold more strongly than Tet.{17508,17511} Moreover, anhydrotetracycline poorly binds the 30S ribosomal subunit, compared to Tet,{17512} so it does not act as a general inhibitor of translation and is a poor antibiotic. Perhaps related to this, the concentration of anhydrotetracycline that inhibits eukaryotic cell growth is more than a 1,000-fold above the dose that alters transcription through TetR.{17508}  

     

    Brand:
    Cayman
    SKU:10009542 - 500 mg

    Available on backorder

    Add to quotes
    Add to quotes
    View product page
  • A zwitterionic glycerophospholipid commonly used in the formation of lipid monolayers

    1,2-Dipalmitoyl-sn-glycero-3-PC – 50 mg

    1,2-Dipalmitoyl-sn-glycero-3-PC (DPPC) is a zwitterionic glycerophospholipid commonly used in the formation of lipid monolayers, bilayers, and liposomes for use in a variety of applications.{14480,24261,14478,14479} It has been used in the formation of proteoliposomes for implantation of γ-glutamyl transpeptidase into human erythrocyte membranes.{14478} Incorporation of glycosphingolipid antigens into DPPC-containing liposomes increases the immunogenicity of the antigens in mice.{14479}  

     

    Brand:
    Cayman
    SKU:10009473 - 50 mg

    Available on backorder

    Add to quotes
    Add to quotes
    View product page